Serina Therapeutics Announces Sale of UniverXome Subsidiary
January 15, 2025 16:05 ET
|
Serina Therapeutics, Inc.
- Transaction eliminates $11.2 million in debt, strengthening financial position - HUNTSVILLE, AL, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics Inc. (“Serina”) (NYSE American: SER), a...
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors
January 14, 2025 17:25 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...